Literature DB >> 16858879

Ropinirole versus placebo in primary restless legs syndrome.

John C Morgan, Kapil D Sethi.   

Abstract

Entities:  

Year:  2006        PMID： 16858879     DOI： 10.1007/s11910-006-0018-7

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN： 1528-4042            Impact factor:   5.081


× No keyword cloud information.
  14 in total

1.  Ropinirole in the treatment of patients with restless legs syndrome: a US-based randomized, double-blind, placebo-controlled clinical trial.

Authors:  Richard K Bogan; June M Fry; Markus H Schmidt; Stanley W Carson; Sally Y Ritchie
Journal:  Mayo Clin Proc       Date:  2006-01       Impact factor: 7.616

2.  Long-term effects of tetrabenazine in hyperkinetic movement disorders.

Authors:  J Jankovic; J Beach
Journal:  Neurology       Date:  1997-02       Impact factor: 9.910

3.  Pathological gambling caused by drugs used to treat Parkinson disease.

Authors:  M Leann Dodd; Kevin J Klos; James H Bower; Yonas E Geda; Keith A Josephs; J Eric Ahlskog
Journal:  Arch Neurol       Date:  2005-07-11

4.  Treatment of restless legs syndrome with levodopa plus benserazide.

Authors:  S Akpinar
Journal:  Arch Neurol       Date:  1982-11

5.  Prevalence and correlates of restless legs syndrome: results from the 2005 National Sleep Foundation Poll.

Authors:  Barbara Phillips; Wayne Hening; Pat Britz; David Mannino
Journal:  Chest       Date:  2006-01       Impact factor: 9.410

6.  Restless legs syndrome improved by pramipexole: a double-blind randomized trial.

Authors:  J Montplaisir; A Nicolas; R Denesle; B Gomez-Mancilla
Journal:  Neurology       Date:  1999-03-23       Impact factor: 9.910

Review 7.  Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health.

Authors:  Richard P Allen; Daniel Picchietti; Wayne A Hening; Claudia Trenkwalder; Arthur S Walters; Jacques Montplaisi
Journal:  Sleep Med       Date:  2003-03       Impact factor: 3.492

8.  Treatment of hyperkinetic movement disorders with tetrabenazine: a double-blind crossover study.

Authors:  J Jankovic
Journal:  Ann Neurol       Date:  1982-01       Impact factor: 10.422

9.  Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study.

Authors:  Arthur S Walters; William G Ondo; Tilman Dreykluft; Ron Grunstein; Daniel Lee; Kapil Sethi
Journal:  Mov Disord       Date:  2004-12       Impact factor: 10.338

10.  Sudden onset of sleep and dopaminergic therapy in patients with restless legs syndrome.

Authors:  Jens Carsten Möller; Yvonne Körner; Werner Cassel; Charlotte Meindorfner; Hans-Peter Krüger; Wolfgang H Oertel; Karin Stiasny-Kolster
Journal:  Sleep Med       Date:  2006-03-22       Impact factor: 3.492
View more
  1 in total

1.  Efficacy and safety of pramipexole in restless legs syndrome.

Authors:  John C Morgan; Kapil D Sethi
Journal:  Curr Neurol Neurosci Rep       Date:  2007-07       Impact factor: 5.081
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.